Georgia Code
Article 3 - Personnel
§ 31-11-55.1. Opioid Antagonists Administered by First Responder to Save Life of Person Experiencing Opioid Related Overdose

History. Code 1981, § 31-11-55.1 , enacted by Ga. L. 2014, p. 683, § 2-6/HB 965.
Editor’s notes.
Ga. L. 2014, p. 683, § 2-1/HB 965, not codified by the General Assembly, provides:
“WHEREAS, Naloxone is an opioid antagonist developed to counter the effects of opiate overdose, specifically the life threatening depression of the central nervous and respiratory systems; and
“WHEREAS, Naloxone is clinically administered via intramuscular, intravenous, or subcutaneous injection; and
“WHEREAS, Naloxone is administered outside of a clinical setting or facility intranasally via nasal atomizer; and
“WHEREAS, the American Medical Association supported the lay administration of this life saving drug in 2012; and
“WHEREAS, similar Naloxone access laws have reversed more than 10,000 opioid overdoses by lay people in other states; and
“WHEREAS, the American Medical Association acknowledged that ‘fatalities caused by opioid overdose can devastate families and communities, and we must do more to prevent these unnecessary deaths’; and
“WHEREAS, the National Institutes of Health found that Naloxone ‘lacks any psychoactive or addictive qualities . . . without any potential for abuse . . . [and] medical side effects or other problematic unintended consequences associated with Naloxone have not been reported’; and
“WHEREAS, any administration of Naloxone to an individual experiencing an opioid overdose must be followed by professional medical attention and treatment.”
Ga. L. 2014, p. 683, § 3-1/HB 965, not codified by the General Assembly, provides, in part, that Parts I and II of this Act shall apply to all acts committed on or after April 24, 2014.

Structure Georgia Code